Comparison of lipid and non-lipid markers of atherosclerosis in arterial versus venous blood

被引:4
|
作者
Palmer, B
Watson, LE [1 ]
Riggs, MW
Lawrence, M
Baisden, CE
McNeal, CJ
Macfarlane, RD
机构
[1] Texas A&M Univ Syst, Coll Med,Ctr Hlth Sci, Cardiac & Vasc Inst,Scott & White Mem Hosp & Clin, Scott Sherwood & Brinley Fdn, Temple, TX 76508 USA
[2] Texas A&M Univ Syst, Coll Med,Ctr Hlth Sci, Dept Biostat,Scott & White Mem Hosp & Clin, Scott Sherwood & Brinley Fdn, Temple, TX 76508 USA
[3] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA
关键词
D O I
10.1258/000456303321610637
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Early studies have suggested that there may be differences in the concentration of lipoprotein particles and their associated apolipoproteins in arterial and venous blood and that this gradient might explain a proclivity to develop atherosclerotic lesions. The aim of this study was to use current methods of analysis to determine levels of these components, including particle densities and several common inflammatory markers in arterial and venous blood. Methods Samples of arterial and venous blood were obtained nearly simultaneously in 26 patients undergoing right and left heart catheterization. Analyses were performed using enzymatic, immunoturbidimetric and ultracentrifugation assays. Results Data obtained for total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, HDL and LDIL particle density, high sensitivity C-reactive protein, serum amyloid-A and apoprotein B-100 concentrations in arterial and venous blood did not demonstrate any significant difference in the means. Conclusion Arterial and venous blood can be used interchangeably to study the effect of blood concentrations of common soluble surrogate markers of atherosclerosis.
引用
收藏
页码:286 / 288
页数:3
相关论文
共 50 条
  • [21] Evaluating the therapeutic profiles of lipid and non-lipid based dry eye supplements
    Craig, Jennifer P.
    Jones, Lyndon William
    Willcox, Mark
    James, Wolffsohn
    Muntz, Alex
    Luensmann, Doerte
    Tan, Jacqueline
    Trave-Huarte, Sonia
    Wang, Michael T. M.
    Xue, Ally L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [22] Present-day uses of niacin: effects on lipid and non-lipid parameters
    Sanyal, Sanjukta
    Karas, Richard H.
    Kuvin, Jeffrey T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1711 - 1717
  • [23] Prevalence of hypertension and other lipid and non-lipid risk factors in stroke.
    Giovannetti, R
    Brunelleschi, G
    Del Corso, C
    Panlgada, G
    Giuntoli, F
    Saba, P
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 197A - 197A
  • [25] Comparison of lipid profile and blood sugar between peripheral venous, peripheral arterial and coronary artery blood samples
    Dehghani, M
    Saneei, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 234 - 234
  • [26] Carotid stenosis and the role of non-lipid factors.
    Ercolini, L
    Chiti, E
    Pulli, R
    Anichini, M
    Cesaretti, S
    Lepori, M
    Pratesi, C
    ATHEROSCLEROSIS, 1999, 145 : S21 - S21
  • [27] NON-LIPID OSMIOPHILIC GRANULES IN PRESYNAPTIC NEUROPLASMA OF BOUTONS
    VONMIHALIK, P
    ZEITSCHRIFT FUR ZELLFORSCHUNG UND MIKROSKOPISCHE ANATOMIE, 1966, 75 (03): : 537 - +
  • [28] Sloe allergy: is a non-lipid transfer protein involved?
    Basagana, M.
    Depreux, N.
    Lombardero, M.
    ALLERGY, 2012, 67 : 213 - 214
  • [29] LIPID-MODULATED FLUIDITY CHANGES MAY BE DEPENDENT ON ORGANIZATION BY NON-LIPID COMPONENTS
    SMITH, AD
    STUBBS, CD
    WEYMAN, C
    TSANG, W
    BELIN, J
    JOHNSON, SM
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1978, 359 (09): : 1152 - 1152
  • [30] Silica-Lipid Hybrid (SLH) Versus Non-lipid Formulations for Optimising the Dose-Dependent Oral Absorption of Celecoxib
    Angel Tan
    Andrew K. Davey
    Clive A. Prestidge
    Pharmaceutical Research, 2011, 28 : 2273 - 2287